Rodman & Renshaw Reiterates Buy Rating on Compugen (CGEN)

March 4, 2025 10:26 AM

Rodman & Renshaw analyst Tony Blair reiterated a Buy rating and $4.00 price target on Compugen (NASDAQ: CGEN).The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found